Stocks-PACB-Pacific Biosciences of California Inc

PACB Pacific Biosciences of California Inc

11.40 -0.32 (-2.71%)
Market OpenDelayed Prices By NASDAQ, in USD
Trade
Stocks-PACB-Pacific Biosciences of California Inc
PACB Pacific Biosciences of California Inc
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Pacific Biosciences of California Inc's revenues decreased by 1.73% and amounted to 128.25M. Net income decreased by NaN to N/A. Net assets decreased by NaN to N/A and EPS decreased from -0.89 to N/A.
PACB's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
29.97%
Net Profit Margin
-113.90%
Operating Margin
-207.35%
Return On Investment
-38.00%